drugset / Trial / NCT02871882
Ox Bile- Conjugated Bile Acids Sodium in Type II Diabetes Mellitus
RandomizedParallel-groupTriple-blindTreatment
Summary
To study the effect of an ileocolonic formulation of ox bile extract on insulin sensitivity, postprandial glycemia and incretin levels, gastric emptying, body weight and fasting serum FGF-19 (fibroblast growth factor) levels in overweight or obese type 2 diabetic subjects on therapy with DPP4 (dipeptidyl peptidase-4) inhibitors (e.g. sitagliptin) alone or in combination with metformin.
Timeline
- Start
- 2016-09-15
- Primary completion
- 2017-10-18
- Completion
- 2017-10-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Conjugated bile acids sodium | Unknown | 500 mg | Oral |